1.4700
08-May-25 15:45:00
15 minutes delayed
Stocks
-0.1400
-8.70%
Today's range
1.4500 - 1.6500
ISIN
N/A
Source
NASDAQ
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
30 Jan 2025 06:00:00 By Nasdaq GlobeNewswire